Pancreatic Cancer Imaging: A New Look at an Old Problem.

Computed tomography is the most commonly used imaging modality to detect and stage pancreatic cancer. Previous advances in pancreatic cancer imaging have focused on optimizing image acquisition parameters and reporting standards. However, current state-of-the-art imaging approaches still misdiagnose some potentially curable pancreatic cancers and do not provide prognostic information or inform optimal management strategies beyond stage. Several recent developments in pancreatic cancer imaging, including artificial intelligence and advanced visualization techniques, are rapidly changing the field. The purpose of this article is to review how these recent advances have the potential to revolutionize pancreatic cancer imaging.

[1]  Jin‐Young Jang,et al.  of the pancreas , 2017 .

[2]  Zhongqiu Wang,et al.  The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis , 2018, Cancer Imaging.

[3]  J. Ayuso,et al.  Preoperative Staging and Tumor Resectability Assessment of Pancreatic Cancer: Prospective Study Comparing Endoscopic Ultrasonography, Helical Computed Tomography, Magnetic Resonance Imaging, and Angiography , 2004, American Journal of Gastroenterology.

[4]  D. Hu,et al.  Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole‐tumor CT texture analysis as quantitative biomarkers , 2018, Cancer medicine.

[5]  Zhongqiu Wang,et al.  Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade , 2018, Abdominal Radiology.

[6]  D. Melisi,et al.  CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy , 2018, AntiCancer Research.

[7]  Yan Wang,et al.  Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience. , 2019, Journal of the American College of Radiology : JACR.

[8]  Naoki Suzuki,et al.  Clinical application of navigation surgery using augmented reality in the abdominal field , 2015, Surgery Today.

[9]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[10]  K. Ohtomo,et al.  Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. , 1997, Radiology.

[11]  Franz A. Fellner,et al.  Introducing Cinematic Rendering: A Novel Technique for Post-Processing Medical Imaging Data , 2016 .

[12]  K. Kim,et al.  Preoperative CT texture features predict prognosis after curative resection in pancreatic cancer , 2019, Scientific Reports.

[13]  Bohyoung Kim,et al.  Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection , 2018, Scientific Reports.

[14]  Sara Broggi,et al.  Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty. , 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[15]  Jayasree Chakraborty,et al.  Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[16]  Mithat Gönen,et al.  Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients , 2017, PloS one.

[17]  Simon Wildermuth,et al.  Cinematic rendering – an alternative to volume rendering for 3D computed tomography imaging , 2016, Insights into Imaging.

[18]  G. Mai,et al.  Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems , 2015, Medicine.

[19]  A. Yuille,et al.  Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features. , 2020, Diagnostic and interventional imaging.

[20]  Pietro Mancosu,et al.  Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma , 2019, PloS one.

[21]  Amber L. Simpson,et al.  CT radiomics to predict high‐risk intraductal papillary mucinous neoplasms of the pancreas , 2018, Medical physics.

[22]  Zhongqiu Wang,et al.  Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography , 2018, Abdominal Radiology.

[23]  Yuhsiang M. Tsai,et al.  Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validation. , 2020, The Lancet. Digital health.

[24]  P. Williams,et al.  Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features , 2019, Abdominal Radiology.

[25]  Xuelei Ma,et al.  Discrimination of Pancreatic Serous Cystadenomas From Mucinous Cystadenomas With CT Textural Features: Based on Machine Learning , 2019, Front. Oncol..

[26]  Dongsheng Gu,et al.  CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study , 2019, European Radiology.

[27]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[28]  J G Fletcher,et al.  Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. , 2004, AJR. American journal of roentgenology.

[29]  David L. Masica,et al.  A multimodality test to guide the management of patients with a pancreatic cyst , 2019, Science Translational Medicine.

[30]  Moritz H Albrecht,et al.  Cinematic Rendering in CT: A Novel, Lifelike 3D Visualization Technique. , 2017, AJR. American journal of roentgenology.

[31]  L. Wood,et al.  Why is pancreatic cancer so deadly? The pathologist's view , 2019, The Journal of pathology.

[32]  Alan L. Yuille,et al.  Multi-Scale Coarse-to-Fine Segmentation for Screening Pancreatic Ductal Adenocarcinoma , 2018, MICCAI.

[33]  Alan L. Yuille,et al.  Deep Supervision for Pancreatic Cyst Segmentation in Abdominal CT Scans , 2017, MICCAI.

[34]  Leonid L. Chepelev,et al.  Applying Modern Virtual and Augmented Reality Technologies to Medical Images and Models , 2018, Journal of Digital Imaging.

[35]  U. Motosugi,et al.  Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. , 2011, Radiology.

[36]  Abhishek Midya,et al.  Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation , 2019, European Radiology.

[37]  C. Matos,et al.  Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy. , 2018, Radiology.

[38]  Zhongqiu Wang,et al.  Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography , 2018, Acta radiologica.

[39]  S. Jung,et al.  MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome , 2018, Abdominal Radiology.

[40]  Timothy J Ziemlewicz,et al.  Opportunistic Osteoporosis Screening at Routine Abdominal and Thoracic CT: Normative L1 Trabecular Attenuation Values in More than 20 000 Adults. , 2019, Radiology.

[41]  Geoffrey G. Zhang,et al.  Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms , 2016, Oncotarget.

[42]  Eliot Siegel,et al.  Implementing Virtual and Augmented Reality Tools for Radiology Education and Training, Communication, and Clinical Care. , 2019, Radiology.

[43]  Caroline Reinhold,et al.  Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes. , 2017, European journal of radiology.

[44]  Mark Tann,et al.  CT texture analysis of pancreatic cancer , 2018, European Radiology.

[45]  Joon Koo Han,et al.  Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis , 2018, Acta radiologica.

[46]  A. Scarpa,et al.  CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms , 2019, Scientific Reports.

[47]  Wei Shen,et al.  Segmentation for Classification of Screening Pancreatic Neuroendocrine Tumors , 2020, 2021 IEEE/CVF International Conference on Computer Vision Workshops (ICCVW).

[48]  Masoom A. Haider,et al.  CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma – a quantitative analysis , 2017, BMC Medical Imaging.

[49]  A. Yuille,et al.  Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue. , 2019, AJR. American journal of roentgenology.

[50]  B. Erickson,et al.  Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study , 2017, PloS one.

[51]  Joel G Fletcher,et al.  Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. , 2003, Radiology.

[52]  Elliot K Fishman,et al.  Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. , 2014, Radiology.

[53]  C. Pal,et al.  Deep Learning: A Primer for Radiologists. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[54]  Zheng-yu Jin,et al.  Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy. , 2019, European journal of radiology.

[55]  Dorin Comaniciu,et al.  Shaping the Future through Innovations: From Medical Imaging to Precision Medicine , 2016, Medical Image Anal..

[56]  M. Cabana,et al.  Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. , 2019, JAMA.

[57]  Elliot K Fishman,et al.  MDCT Angiography With 3D Rendering: A Novel Cinematic Rendering Algorithm for Enhanced Anatomic Detail. , 2017, AJR. American journal of roentgenology.

[58]  Elliot K. Fishman,et al.  Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors , 2020, Abdominal Radiology.

[59]  K. Lillemoe,et al.  Screening for Pancreatic Cancer Gets a D, But the Student Is Improving. , 2019, JAMA surgery.

[60]  Murray F. Brennan,et al.  Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas , 2004, Annals of surgery.

[61]  Fanny Orlhac,et al.  Validation of A Method to Compensate Multicenter Effects Affecting CT Radiomics. , 2019, Radiology.

[62]  L. Chu,et al.  Deep learning for pancreatic cancer detection: current challenges and future strategies. , 2020, The Lancet. Digital health.

[63]  K. Ohtomo,et al.  Development of pancreatic cancer is predictable well in advance using contrast-enhanced CT: a case–cohort study , 2017, European Radiology.

[64]  Yi Guo,et al.  Computer-Aided Diagnosis of Pancreas Serous Cystic Neoplasms: A Radiomics Method on Preoperative MDCT Images , 2019, Technology in cancer research & treatment.

[65]  Sang Joon Park,et al.  CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis , 2018, European Radiology.

[66]  A. Yuille,et al.  Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls , 2020, Abdominal Radiology.

[67]  Ziding Feng,et al.  Quantitative imaging to evaluate malignant potential of IPMNs , 2016, Oncotarget.

[68]  L. Østergaard,et al.  Pancreatic magnetic resonance imaging texture analysis in chronic pancreatitis: a feasibility and validation study , 2020, Abdominal Radiology.

[69]  Wenli Qiu,et al.  Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images , 2019, Front. Oncol..

[70]  Elliot K Fishman,et al.  Cinematic rendering of pancreatic neoplasms: preliminary observations and opportunities , 2018, Abdominal Radiology.

[71]  Perry J Pickhardt,et al.  CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[72]  Yun Bian,et al.  Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma , 2019, Pancreas.

[73]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[74]  Michael Goggins,et al.  Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages , 2015, Gut.

[75]  Yun Bian,et al.  Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer , 2020, Abdominal Radiology.

[76]  Q. Feng,et al.  Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database. , 2019, International journal of surgery.

[77]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[78]  A. Aisen,et al.  Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group. , 1995, Radiology.

[79]  D. Sahani,et al.  Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis. , 2017, AJR. American journal of roentgenology.

[80]  T. Ichikawa,et al.  Pancreatic Adenocarcinoma: MDCT Versus MRI in the Detection and Assessment of Locoregional Extension , 2006, Journal of computer assisted tomography.

[81]  Naoki Suzuki,et al.  Navigation Surgery Using an Augmented Reality for Pancreatectomy , 2015, Digestive Surgery.

[82]  B. Erickson,et al.  Machine Learning for Medical Imaging. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[83]  Vikesh K. Singh,et al.  Radiomic features of the pancreas on CT imaging accurately differentiate functional abdominal pain, recurrent acute pancreatitis, and chronic pancreatitis. , 2019, European journal of radiology.

[84]  H. Pitt,et al.  Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. , 1995, Radiology.

[85]  Amber L. Simpson,et al.  Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis , 2018, Annals of Surgical Oncology.